The nexium market is poised for significant growth, driven by several key factors.1 The global market for nexium--------------------------------------------
The nexium market is experiencing significant growth, driven by several key factors.
The demand for effective treatment for obesity, including esomeprazole, liraglutide, andomeprazole sulfate, is a significant contributor to the market's expansion.3 Esomeprazole, a nonsteroidal anti-inflammatory drug (NSAID), is recognized for its efficacy in reducing weight.3
The therapeutic benefits of liraglutide are significant.3 As liraglutide targets the gastrointestinal (GI) tract, it is more accessible and affordable than nexium.3,4 Esomeprazole, a proton pump inhibitor, is approved by the FDA for the treatment of gastroesophageal reflux disease (GERD),2,5,6 esomeprazole is approved for the treatment of proton pump inhibitors (PPIs), and liraglutide is approved for the treatment of gastroesophageal reflux disease (GERD),7
Esomeprazole (Nexium) - Nexium (esomeprazole) 20 mg/20 mg Tablet 24 Tablets 8 x 7 x 3 (Box)The market for esomeprazole, liraglutide, and omeprazole, however, is still limited.3 Esomeprazole, a proton pump inhibitor, is recognized for its efficacy in reducing weight.3 Esomeprazole, a nonsteroidal anti-inflammatory drug (NSAID) is a popular medication used to relieve inflammation and pain in conditions like gastroesophageal reflux disease (GERD),2,5,6 esomeprazole is approved for the treatment of GERD,3,7 liraglutide, a PPI, and proton pump inhibitors (PPIs) are approved by the FDA for the treatment of proton pump inhibitors (OTAL prescription).3
The market for liraglutide, a medication used to treat proton pump inhibitors, is also experiencing significant growth.3,7 The patent for liraglutide's generic equivalent, esomeprazole, expired in October 2023, allowed generic manufacturers to offer their products without the need for prior sale.3,8
Several factors are driving the growth of the nexium market:
The increasing healthcare expenditure is a significant driver. Drug costs are expected to continue to contribute to the market's growth.3
The increasing healthcare system accessibility and advancements in medical technologies are also contributing to the growth of the nexium market.3
The growing geriatric population and the growing geriatric care system are areas in which the market is expected to grow.3
Despite the growth, the nexium market faces certain restraints:
The market has also faced challenges such as:
The patent for esomeprazole's generic equivalent, Nexium, expired in October 2023, allowed generic manufacturers to offer their products without sales.3
The high cost of medications and the difficulty of obtaining them all have also pose challenges.3
The patent for Nexium expired in October 2023, allowing generic manufacturers to offer their products without sales.3
The difficulty of obtaining and maintaining various patents has also led to increased competition.3
The nexium market is becoming a lucrative bright spots for growth. With the increasing healthcare expenditure and the growing geriatric population, the market presents numerous opportunities for growth.3
The market is also experiencing opportunities for innovation with the potential to :
The market is poised for growth with the potential to :
Improve the treatment response and cure-all outcomes for diseases.3
The cost of esomeprazole, liraglutide, and omeprazole, as well as proton pump inhibitors, is significant cost considerations. The market value of liraglutide, the generic equivalent of nexium, ranges from $11.60 to $48.08 per tablet, versus $8.83 per tablet for nexium.
GlaxoSmithKline (GSK), the maker of AstraZeneca's top-selling anti-ulcer drug, Nexium, said it has received final approval from the United States Food and Drug Administration (FDA) to market a generic version of the drug. The company said it will continue to market the drug to physicians in the U. S. and Europe. In the United Kingdom, the generic version of the drug is also expected to be approved by the FDA. In the US, the drug's US patent on Nexium is set to expire in late 2024.
GSK said that its patent for Nexium will expire in March 2024. The patent on the drug expires in 2019, and its US patent on its generic version is set to expire in April.
The drug, which is used to treat acid reflux and ulcers, has been in use for over half a century. It is sold under the brand name Nexium to treat the symptoms of ulcers, such as a burning sensation during sexual intercourse, and is widely known by its brand name, Viagra.
The company said its marketing plan for Nexium included "ongoing research, which resulted in approval for the drug from the U. Food and Drug Administration (FDA)."
It is not clear how long the drug will remain in use. A preliminary report published in March found that its use for the treatment of acid reflux, also known as gastroesophageal reflux disease (GERD), could be halted by the FDA, citing an increased risk of heart attack and stroke.
The FDA said that the company was reviewing the reports, including those from other sources, and its plan has not materialised.
In May, the company said it had received approval for a generic version of Nexium to treat acid reflux.
Nexium, which is available by prescription only, is intended to treat the symptoms of gastroesophageal reflux disease (GERD) and acid reflux caused by the excessive stomach acid.
The FDA has granted the company's request to market a generic version of Nexium in the U. and Europe, where the drug is already in Phase 3 trials.
GSK said it has no plans to introduce generic Nexium to the market.
In October, the company also confirmed that it has received final approvals from the F. D. A. to market a generic version of Nexium for gastroesophageal reflux disease (GERD).
The company said it would continue to market the drug to physicians.
GSK's current marketing plan has not been revealed, which is to launch in the U. in the fourth quarter.
Nexium sales in the U. have been declining for many years. In March, the company's sales force recommended that Nexium be removed from the market.
GSK previously said that the company will continue to market the drug to physicians in the U.
In December 2014, AstraZeneca said it had received FDA approval to market a generic version of Nexium in the U. The approval was given by FDA to Pfizer for a treatment for acid reflux, which is not yet known.
Pfizer is planning to market a generic version of Nexium to its patients in Europe and the United States.
GSK said that its patent on Nexium will expire in 2024.
GSK has no plans to introduce generic Nexium to the market.
AstraZeneca said that the company has received final approvals for a generic version of Nexium in the U.
In the United States, the generic version of Nexium is expected to be approved by the FDA in March.
Pfizer said it had no plans to introduce generic Nexium to the market. The company will be launching its generic Nexium in the U.AstraZeneca said it had no plans to introduce generic Nexium to the market.Nexium, the most widely used anti-ulcer drug, is one of the top selling medicines worldwide. The drug is also widely used to treat GERD, which affects around 1 in 4 American adults. AstraZeneca's Nexium patent in the US expires in September 2021.
GSK said that its patent on Nexium will expire in April 2024.
Nexium® 24HR 20mg Mini Capsules provide lasting relief from frequent heartburn and acid reflux in a 53% smaller capsule (based on volume of the capsule vs Nexium® 24HR Once Daily Dosing Tablet)
Nexium 24 Hour Once Daily Dosing provides lasting relief for frequent heartburn & acid reflux.
Boxed Contents: 14 Mini Capsules Size: 14 Mini Capsules
Do not use:
CAUTION Always read the label. Follow the directions for use.
Each capsule contains Esomeprazole magnesium trihydrate 22.3mg (equivalent to esomeprazole 20mg)
Active Ingredients: Each capsule contains Esomeprazole magnesium trihydrate 22.3mg (equivalent to esomeprazole 20mg)
Adults 18 years, of age and over: Take 1 capsule daily for at least 7 days and up to 14 days.
Swallow the capsule whole with water, with or without food.
Do not crush, chew or open, or take by mouth.
Lab investigations show that Esomeprazole 20mg tablets contain Esomeprazole 20mg.
Do not take if allergic to esomeprazole or any other listed ingredients.
Do not take if if allergic to esomeprazole.
Do not take if if if if if if if if if if if if if
Each Esomeprazole magnesium trihydrate 22.3mg/g
Active Ingredients: Esomeprazole magnesium trihydrate 22.3mg
Adults 18 years of age and over: Take 1 capsule daily for at least 7 days and up to 14 days.
Swallow the capsule by mouth.
Do not crush, chewing the capsule whole.
Do not take if if if if if if if if
Alternate Name:Pharmapure RX Esomep-EZS
Description:Nexium treats gastroesophageal reflux disease (GERD), esophagitis, and stomach ulcers. The generic version of Nexium is esomeprazole magnesium. For a supply of 30 oral tablets of Nexium Delayed-Release Capsules 40 mg is approximately $287. Take advantage of our LowerMyRx discount to receive a typical Nexium discount of up to 80% off of the retail price at participating pharmacies near you.
Dosage Form:Capsule Delayed Release
Administration Route:By mouth
Drug Class:Gastric Acid Secretion Inhibitor, Gastrointestinal Agent
Generic Available:Yes
Strength:20 MG
Warnings:Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, liver disease, lupus, vitamin B12 deficiency, or osteoporosis. This medicine may cause the following problems: Kidney problems, including acute tubulointerstitial nephritisIncreased risk of broken bones in the hip, wrist, or spine (more likely if used several times per day or longer than 1 year)Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug reaction with eosinophilia and systemic symptoms (DRESS)LupusFundic gland polyps (abnormal growth in the upper part of your stomach) This medicine can cause diarrhea. Call your doctor if the diarrhea becomes severe, does not stop, or is bloody. Do not take any medicine to stop diarrhea until you have talked to your doctor. Diarrhea can occur 2 months or more after you stop taking this medicine. Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments. Keep all medicine out of the reach of children. Never share your medicine with anyone. Stomach pain, nausea, vomiting, weight loss, bloody or black stools
Food Warnings:Do not use esomeprazole if you are also using medicines that contain rilpivirine., Some medicines can affect how esomeprazole works. Tell your doctor if you are using any of the following: Atazanavir, cilostazol, diazepam, digoxin, erlotinib, ketoconazole, methotrexate, mycophenolate mofetil, nelfinavir, rifampin, saquinavir, St John's wort, tacrolimus, voriconazoleBlood thinner (including clopidogrel or warfarin)Diuretic (water pill)Iron supplements, This medicine can cause diarrhea. Diarrhea can occur 2 months or more after you stop taking this medicine., Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results., Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments., Keep all medicine out of the reach of children.
AppointancerNexium Delayed-Release Capsules
Nexium is used to treat frequent heartburn, acid reflux, and indigestion. It also treats acid reflux caused by cancer, brain or blood vessel disease, or an inherited condition like cancer of the lining of the stomach. Nexium Delayed-Release Capsules are for single-use use use.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$35.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
StoreraintsStoreGastroHealthylife provides not aall all all all-all, but we offer a few things to help you decide what you can buy.
Stade de France Pharmacy